Several approaches for anticancer drug development progress

Abstract

Anticancer drug development is facing increasingly challenge. Much more chemicals or bio-agents are required to be evaluated every year. High-quality and speediness of drug evaluation requires joint-efforts between chemists and pharmacologists. This Editorial provides this area of anticancer drug discovery, development and licensing.